MDxHealth (MDXH) Net Margin (2022 - 2026)

MDxHealth (MDXH) posted Net Margin of 32.38% for Q1 2026, up 207.15% sequentially from 30.22% in Q4 2025, and down 553.0% YoY from 7.15% in Q1 2025.

MDxHealth (MDXH) Net Margin (2022 - 2026) Analysis & Trends

MDxHealth has reported Net Margin for 5 years, with the latest figure at 32.38% in Q1 2026.

Quarterly Net Margin fell 553.0% year-over-year to 32.38% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 13.28% (up 825.0% YoY) and the FY2025 annual result came in at 31.07%, up 1120.0% from the prior year.
Net Margin grew to 32.38% in Q1 2026 per MDXH's latest filing, from 30.22% in the prior quarter.
Over five years, Net Margin peaked at 96.49% in Q4 2022 and troughed at 121.05% in Q3 2022.
A 5-year average of 16.04% and a median of 30.22% in 2025 frame the typical range for Net Margin.
The widest YoY moves for Net Margin: up 12256 bps in 2024, down 8292 bps in 2024.
Over 5 years, Net Margin stood at 96.49% in 2022, then tumbled by 43 bps to 55.26% in 2023, then tumbled by 150 bps to 27.65% in 2024, then retreated by 9 bps to 30.22% in 2025, then soared by 207 bps to 32.38% in 2026.
According to Business Quant data, Net Margin over the past three periods registered 32.38%, 30.22%, and 31.39% for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Margin (Qtr)
1	Thermo Fisher Scientific	213.88 Bn	209.81 Bn	8.34 Bn	14.65%
2	Danaher	140.65 Bn	136.30 Bn	3.61 Bn	13.89%
3	Idexx Laboratories	46.02 Bn	45.83 Bn	779.09 Mn	27.82%
4	Agilent Technologies	39.85 Bn	38.05 Bn	990.00 Mn	18.47%
5	Iqvia Holdings	39.20 Bn	37.12 Bn	1.44 Bn	5.52%
6	Natera	38.80 Bn	37.70 Bn	696.04 Mn	-12.22%
7	Illumina	30.11 Bn	28.94 Bn	770.00 Mn	17.86%
8	Mettler Toledo International	28.66 Bn	28.61 Bn	650.22 Mn	22.67%
9	Quest Diagnostics	26.24 Bn	25.61 Bn	1.03 Bn	10.65%
10	MDxHealth	21.81 Mn	-21.34 Mn	16.61 Mn	-32.38%

Download Data